Chickenpox Management in India
For chickenpox management in India, focus on supportive care for healthy children, but use oral acyclovir within 24 hours of rash onset for high-risk groups (persons >12 years, immunocompromised patients, chronic disease patients), and intravenous acyclovir for severe complications like pneumonia or encephalitis. 1
General Management Approach
Healthy Children (<12 years)
- Supportive care is sufficient for most healthy children with uncomplicated chickenpox
- Acyclovir is not routinely recommended as the clinical benefit does not justify routine use in this population 1
- The medication reduces fever duration and lesion count but does not decrease transmission or school absence 1
High-Risk Groups Requiring Acyclovir
Oral acyclovir should be considered for:
- Persons aged >12 years (adolescents and adults)
- Patients with chronic cutaneous or pulmonary disorders
- Those receiving long-term salicylate therapy
- Patients on short, intermittent, or aerosolized corticosteroids
- Secondary household contacts (some experts recommend)
- Immunocompromised individuals 1
Critical timing: Must be initiated within 24 hours of rash onset for effectiveness 1
Severe Complications Requiring IV Acyclovir
Intravenous acyclovir is indicated for:
- Varicella pneumonia (mortality reaches 50% in those requiring mechanical ventilation in India) 2
- Acute meningoencephalitis or myelitis
- Hemorrhagic complications
- Hepatitis
- Any immunocompromised patient with varicella 1, 2, 3
Indian data shows: Adult varicella has 68% organ involvement rate, with pneumonia (34%), hepatitis (24%), and hemorrhagic complications (24%) being most common. In-hospital mortality is 18%, rising to 41% with pneumonia 3. This underscores the importance of early antiviral therapy in adults.
Post-Exposure Prophylaxis
Vaccination
- Preferred method for healthy susceptible individuals after exposure
- Not indicated for prophylactic acyclovir use 1
VZIG (Varicella-Zoster Immune Globulin)
Indicated for immunocompromised patients without immunity:
- Dose: 125 units/10 kg body weight (maximum 625 units)
- Must be given after significant exposure (>5 minutes face-to-face contact indoors, or household exposure)
- Extends incubation period from 10-21 days to >28 days 1
Special Considerations for India
Vaccination Context
- Varicella vaccine is not included in India's Universal Immunization Program despite WHO 2014 recommendations for two-dose schedules 4
- Available as private vaccination: two doses recommended at 15-18 months and 4-6 years 5
- Single-dose effectiveness: 85%; two-dose: 92% 5
- Indigenous vaccine (Bio Pox™) shows 80% seroconversion, comparable to international vaccines 6
Epidemiological Patterns in India
- Seasonal peak: March-April, though cases occur year-round 3
- Higher adult susceptibility: Nearly 30% of Indian adolescents lack protective antibodies 6
- VZV spreads less readily in tropical climates, resulting in more susceptible adults compared to temperate countries 7
- Breakthrough infections occur even in vaccinated immunocompromised patients 5
Common Pitfalls to Avoid
Delayed acyclovir initiation: The 24-hour window from rash onset is critical—effectiveness drops significantly after this period 1
Underestimating adult disease severity: Even previously healthy adults develop severe complications in India; advanced age independently predicts mortality (OR 1.144) 3
Inappropriate antibiotic use: Antibiotics are not indicated unless secondary bacterial infection is documented 1
Aspirin use: Avoid in children due to Reye's syndrome risk (relevant for those on long-term salicylate therapy) 1
Assuming immunity in immunocompromised: Bone marrow transplant recipients should be considered non-immune regardless of prior history 1
Pregnancy Considerations
- Acyclovir is FDA Category B
- Not routinely recommended for pregnant women with uncomplicated varicella
- IV acyclovir should be considered for serious complications like pneumonia 1
- VZIG reduces infection rate to 30% in exposed pregnant women without immunity 1
Monitoring for Complications
Watch for signs requiring escalation: